Prof. Amer Zeidan and guest experts dive into the latest innovations in molecular testing, emerging therapies & targeted treatments in R/R acute myeloid leukemia #AML in this vodcast series.

All episodes available now 👉 buff.ly/ro4GLtX

#OncSky #HaemOnc

Cognitive impairment is associated with altered blood cell profiles in aggressive lymphoma - Supportive Care in Cancer Purpose Cognitive and psychological symptoms in neuropsychiatric disorders have been linked to blood cell parameters, including neutrophil-to-lymphocyte ratios (NLRs), systemic immune-inflammation ind...

🚨New paper🚨 We found #CognitiveImpairment was associated with blood cell parameters in individuals with aggressive lymphoma, indicating distinct biological patterns of dysfunction before, during, and after chemotherapy.
#HaemOnc #SurvOnc #SuppOnc #CRCI
link.springer.com/article/10.1...

Prof. Amer Zeidan and guest experts dive into the latest innovations in molecular testing, emerging therapies & targeted treatments in R/R acute myeloid leukemia #AML in this vodcast series.

All episodes available now 👉 buff.ly/ro4GLtX

#OncSky #HaemOnc

With #ASH2025 at an end, continue your learning in #HaemOnc

Hear directly from #AML experts about innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients.

All episodes now available 👉 buff.ly/ro4GLtX

#HaemSky

The holistic model of leukaemia survivorship care: derived from a qualitative exploration of leukaemia survivorship - Supportive Care in Cancer Purpose Increasing survival rates have left many leukaemia survivors with debilitating effects from the disease and its treatments. However, little is known about the persistent unmet needs of people ...

We identified key domains and stages common across #leukaemia #survivorship, presented in our proposed Holistic Model of Leukaemia Survivorship (HMLS), addressing these domains are critical to the provision of quality survivorship care. #OzOnc #HaemOnc #SurvOnc

link.springer.com/article/10.1...